एंडोक्रिनोलॉजी और मेटाबोलिक सिंड्रोम
खुला एक्सेस

अमूर्त

Position of Incretin Agents in the Traitement of Type 2 Diabetes Mellitus: Literature Review

Sara Deghima, Smina Yahiaoui and Aissa Boudiba

Type 2 diabetes is a chronic and progressive pathology that requires monitoring and supervision for life, its management is difficult and requires continuous efforts with essential therapeutic scaling for the maintaining good glycemic balance. Incretin agents are a new class of drugs that enriches the medical arsenal already available to treat type 2 diabetes; they represent a promising therapeutic option, because they do not cause hypoglycemia while having a beneficial or neutral effect on weight or even a reduction in cardiovascular risk. Through this literature review, we will explain the place of incretin agents in the management of type 2 diabetes and their interest.